Is it time for computable evidence synthesis?
Where this comes from
- Record sourced from PubMed, PMID 32337600.
- Also identified by DOI 10.1093/jamia/ocaa035 and PMC identifier 7309243.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Efforts aimed at increasing the pace of evidence synthesis have been primarily focused on the use of published articles, but these are a relatively delayed, incomplete, and at times biased source of study results data. Compared to those in bibliographic databases, structured results data available in trial registries may be more timely, complete, and accessible, but these data remain underutilized. Key advantages of using structured results data include the potential to automatically monitor the accumulation of relevant evidence and use it to signal when a systematic review requires updating, as well as to prospectively assign trials to already published reviews. Shifting focus to emerging sources of structured trial data may provide the impetus to build a more proactive and efficient system of continuous evidence surveillance.
Medical subject headings
- Clinical Trials as Topic
- Information Storage and Retrieval
- Systematic Reviews as Topic